Genetic basis of congenital cardiovascular malformations

European Journal of Medical Genetics

Volumn 57, Issue 8, 2014, Pages 402-413

  Lalani, Seema R ^a   Belmont, John W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac development; Chromosomal and single gene disorders; Congenital heart defect; Genomic disorder

Indexed keywords

GROWTH FACTOR; TRANSCRIPTION FACTOR;

AORTA ANOMALY; AORTA COARCTATION; AORTA STENOSIS; ARTERIAL TRUNK; ARTICLE; ATRIOVENTRICULAR CANAL; ATRIOVENTRICULAR SEPTAL DEFECT; BICUSPID AORTIC VALVE; CARDIOVASCULAR MALFORMATION; CHROMOSOME ABERRATION; CHROMOSOME DELETION 22Q11; CONGENITAL HEART MALFORMATION; CONGESTIVE CARDIOMYOPATHY; DOWN SYNDROME; FALLOT TETRALOGY; GENE DOSAGE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HEART ATRIUM SEPTUM DEFECT; HEART DEVELOPMENT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HEREDITY; HETEROTAXY SYNDROME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOPLASTIC LEFT HEART SYNDROME; KABUKI MAKEUP SYNDROME; KARYOTYPING; KLEEFSTRA SYNDROME; LUNG VEIN DRAINAGE ANOMALY; MITRAL VALVE PROLAPSE; MOWAT WILSON SYNDROME; MUTATION RATE; PATENT DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PERSISTENT LEFT SUPERIOR VENA CAVA; PULMONARY ARTERY STENOSIS; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; PULMONARY VEIN MALFORMATION; SIGNAL TRANSDUCTION; SOTOS SYNDROME; SYNDROME CHARGE; TRISOMY 13; TRISOMY 18; VASCULAR RING; VELOCARDIOFACIAL SYNDROME; ANIMAL; CARDIOVASCULAR ABNORMALITIES; CLASSIFICATION; GENETICS;

ANIMALS; CARDIOVASCULAR ABNORMALITIES; HUMANS;

EID: 84907597199     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2014.04.010     Document Type: Article

References (171)

1. Arpino C., Brescianini S., Robert E., Castilla E.E., Cocchi G., Cornel M.C., et al. Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 2000, 41:1436-1443.
2. Al Turki S., Manickaraj A.K., Mercer C.L., Gerety S.S., Hitz M.P., Lindsay S., et al. Rare variants in nr2f2 cause congenital heart defects in humans. Am J Hum Genet 2014, 94:574-585.
3. Badaruddoza, Afzal M., Akhtaruzzaman Inbreeding and congenital heart diseases in a north Indian population. Clin Genet 1994, 45:288-291.
4. Balderston S.M., Shaffer E.M., Washington R.L., Sondheimer H.M. Congenital polyvalvular disease in trisomy 18: echocardiographic diagnosis. Pediatr Cardiol 1990, 11:138-142.
5. Bamford R.N., Roessler E., Burdine R.D., Saplakoglu U., dela Cruz J., Splitt M., et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000, 26:365-369.
6. Barriot R., Breckpot J., Thienpont B., Brohee S., Van Vooren S., Coessens B., et al. Collaboratively charting the gene-to-phenotype network of human congenital heart defects. Genome Med 2010, 2:16.
7. Basson C.T., Bachinsky D.R., Lin R.C., Levi T., Elkins J.A., Soults J., et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997, 15:30-35.
8. Battaglia A., Filippi T., Carey J.C. Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision. Am J Med Genet C Semin Med Genet 2008, 148C:246-251.
9. Bauer R.C., Laney A.O., Smith R., Gerfen J., Morrissette J.J., Woyciechowski S., et al. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat 2010, 31:594-601.
10. Baujat G., Le Merrer M. Ellis-van Creveld syndrome. Orphanet J Rare Dis 2007, 2:27.
11. Becker S., Al Halees Z. First-cousin matings and congenital heart disease in Saudi Arabia. Community Genet 1999, 2:69-73.
12. Becker S.M., Al Halees Z., Molina C., Paterson R.M. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet 2001, 99:8-13.
13. Bentham J., Bhattacharya S. Genetic mechanisms controlling cardiovascular development. Ann N Y Acad Sci 2008, 1123:10-19.
14. Bleyl S., Nelson L., Odelberg S.J., Ruttenberg H.D., Otterud B., Leppert M., et al. Agene for familial total anomalous pulmonary venous return maps to chromosome 4p13-q12. Am J Hum Genet 1995, 56:408-415.
15. Bleyl S.B., Saijoh Y., Bax N.A., Gittenberger-de Groot A.C., Wisse L.J., Chapman S.C., et al. Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: integrating evidence from human genetics and model organisms. Hum Mol Genet 2010, 19:1286-1301.
16. Bondy C.A. Aortic dissection in Turner syndrome. Curr Opin Cardiol 2008, 23:519-526.
17. Boneva R.S., Botto L.D., Moore C.A., Yang Q., Correa A., Erickson J.D. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001, 103:2376-2381.
18. Bosley T.M., Alorainy I.A., Salih M.A., Aldhalaan H.M., Abu-Amero K.K., Oystreck D.T., et al. The clinical spectrum of homozygous HOXA1 mutations. Am J Med Genet A 2008, 146A:1235-1240.
19. Botto L.D., Lin A.E., Riehle-Colarusso T., Malik S., Correa A. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 2007, 79:714-727.
20. Botto L.D., May K., Fernhoff P.M., Correa A., Coleman K., Rasmussen S.A., et al. Apopulation-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112:101-107.
21. Breckpot J., Thienpont B., Arens Y., Tranchevent L.C., Vermeesch J.R., Moreau Y., et al. Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects. Cytogenet Genome Res 2011, 135:251-259.
22. Breckpot J., Thienpont B., Peeters H., de Ravel T., Singer A., Rayyan M., et al. Array comparative genomic hybridization as a diagnostic tool for syndromic heart defects. JPediatr 2010, 156:810-817. 817 e1-817 e4.
23. Burn J., Brennan P., Little J., Holloway S., Coffey R., Somerville J., et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 1998, 351:311-316.
24. Burn J., Goodship J. Developmental genetics of the heart. Curr Opin Genet Dev 1996, 6:322-325.
25. Canfield M.A., Honein M.A., Yuskiv N., Xing J., Mai C.T., Collins J.S., et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006, 76:747-756.
26. Carlson M., Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. JMed Genet 2007, 44:745-749.
27. Carey A.S., Liang L., Edwards J., Brandt T., Mei H., Sharp A.J., et al. Effect of copy number variants on outcomes for infants with single ventricle heart defects. Circ Cardiovasc Genet 2013, 6:444-451.
28. Chehab G., Chedid P., Saliba Z., Bouvagnet P. Congenital cardiac disease and inbreeding: specific defects escape higher risk due to parental consanguinity. Cardiol Young 2007, 17:414-422.
29. Ching Y.H., Ghosh T.K., Cross S.J., Packham E.A., Honeyman L., Loughna S., et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 2005, 37:423-428.
30. Cinquetti R., Badi I., Campione M., Bortoletto E., Chiesa G., Parolini C., et al. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum Mutat 2008, 29:468-474.
31. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. NEngl J Med 2006, 354:2443-2451.
32. Correa A., Gilboa S.M., Besser L.M., Botto L.D., Moore C.A., Hobbs C.A., et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008, 199. 237 e1-237 e9.
33. Coucke P.J., Willaert A., Wessels M.W., Callewaert B., Zoppi N., De Backer J., et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 2006, 38:452-457.
34. Cripe L., Andelfinger G., Martin L.J., Shooner K., Benson D.W. Bicuspid aortic valve is heritable. JAm Coll Cardiol 2004, 44:138-143.
35. Czeizel A.E., Toth M., Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996, 53:345-351.
36. Davidsson J., Collin A., Bjorkhem G., Soller M. Array based characterization of a terminal deletion involving chromosome subband 15q26.2: an emerging syndrome associated with growth retardation, cardiac defects and developmental delay. BMC Med Genet 2008, 9:2.
37. De Luca A., Sarkozy A., Ferese R., Consoli F., Lepri F., Dentici M.L., et al. New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle. Clin Genet 2011, 80:184-190.
38. Degenhardt K., Singh M.K., Aghajanian H., Massera D., Wang Q., Li J., et al. Semaphorin 3d signaling defects are associated with anomalous pulmonary venous connections. Nat Med 2013, 19:760-765.
39. Derwinska K., Bartnik M., Wisniowiecka-Kowalnik B., Jagla M., Rudzinski A., Pietrzyk J.J., et al. Assessment of the role of copy-number variants in 150 patients with congenital heart defects. Med Wieku Rozw 2012, 16:175-182.
40. Digilio M.C., Casey B., Toscano A., Calabro R., Pacileo G., Marasini M., et al. Complete transposition of the great arteries: patterns of congenital heart disease in familial precurrence. Circulation 2001, 104:2809-2814.
41. Escudier E., Duquesnoy P., Papon J.F., Amselem S. Ciliary defects and genetics of primary ciliary dyskinesia. Paediatr Respir Rev 2009, 10:51-54.
42. Fakhro K.A., Choi M., Ware S.M., Belmont J.W., Towbin J.A., Lifton R.P., et al. Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci U S A 2011, 108:2915-2920.
43. Ferencz C., Boughman J.A., Neill C.A., Brenner J.I., Perry L.W. Congenital cardiovascular malformations: questions on inheritance. Baltimore-Washington infant study group. JAm Coll Cardiol 1989, 14:756-763.
44. Ferencz C., Loffredo C.A., Corea-Villasenor A., Wilson P.D. Left-sided obstructive lesions, in genetic and environmental risk factors for major cardiovasuclar malformations: The Baltimore-Washington infant study 1981-1989 1997, 165-225. Futura Publishing Co., Inc.
45. Fixler D.E., Pastor P., Chamberlin M., Sigman E., Eifler C.W. Trends in congenital heart disease in Dallas County births. 1971-1984. Circulation 1990, 81:137-142.
46. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
47. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
48. Gebbia M., Ferrero G.B., Pilia G., Bassi M.T., Aylsworth A., Penman-Splitt M., et al. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet 1997, 17:305-308.
49. Giglio S., Graw S.L., Gimelli G., Pirola B., Varone P., Voullaire L., et al. Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation 2000, 102:432-437.
50. Gill H.K., Splitt M., Sharland G.K., Simpson J.M. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. JAm Coll Cardiol 2003, 42:923-929.
51. Goldmuntz E., Paluru P., Glessner J., Hakonarson H., Biegel J.A., White P.S., et al. Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies. Congenit Heart Dis 2011, 6:592-602.
52. Grech V. An excess of tetralogy of Fallot in Malta. JEpidemiol Community Health 1998, 52:280-282.
53. Grech V. Decreased prevalence of hypoplastic left heart syndrome in Malta. Pediatr Cardiol 1999, 20:355-357.
54. Greenway S.C., Pereira A.C., Lin J.C., DePalma S.R., Israel S.J., Mesquita S.M., et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009, 41:931-935.
55. Grossfeld P.D., Mattina T., Lai Z., Favier R., Jones K.L., Cotter F., et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A 2004, 129A:51-61.
56. Gu H., Smith F.C., Taffet S.M., Delmar M. High incidence of cardiac malformations in connexin40-deficient mice. Circ Res 2003, 93:201-206.
57. Hartman R.J., Rasmussen S.A., Botto L.D., Riehle-Colarusso T., Martin C.L., Cragan J.D., et al. The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol 2011, 32:1147-1157.
58. Hernandez-Diaz S., Werler M.M., Walker A.M., Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. NEngl J Med 2000, 343:1608-1614.
59. Hilton E., Johnston J., Whalen S., Okamoto N., Hatsukawa Y., Nishio J., et al. BCOR analysis in patients with OFCD and Lenz microphthalmia syndromes, mental retardation with ocular anomalies, and cardiac laterality defects. Eur J Hum Genet 2009, 17:1325-1335.
60. Hinton R.B., Martin L.J., Tabangin M.E., Mazwi M.L., Cripe L.H., Benson D.W. Hypoplastic left heart syndrome is heritable. JAm Coll Cardiol 2007, 50:1590-1595.
61. Hirayama-Yamada K., Kamisago M., Akimoto K., Aotsuka H., Nakamura Y., Tomita H., et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 2005, 135:47-52.
62. Ho N.K. Congenital malformations in Toa Payoh hospital-a 18 year experience (1972-1989). Ann Acad Med Singap 1991, 20:183-189.
63. Hoess K., Goldmuntz E., Pyeritz R.E. Genetic counseling for congenital heart disease: new approaches for a new decade. Curr Cardiol Rep 2002, 4:68-75.
64. Hoffman J.I. Congenital heart disease: incidence and inheritance. Pediatr Clin North Am 1990, 37:25-43.
65. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. JAm Coll Cardiol 2002, 39:1890-1900.
66. Hoffman J.I., Kaplan S., Liberthson R.R. Prevalence of congenital heart disease. Am Heart J 2004, 147:425-439.
67. Ichida F., Tsubata S., Bowles K.R., Haneda N., Uese K., Miyawaki T., et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation 2001, 103:1256-1263.
68. Insley J. The heritability of congenital heart disease. Br Med J Clin Res Ed 1987, 294:662-663.
69. Irving C.A., Chaudhari M.P. Cardiovascular abnormalities in Down's syndrome: spectrum, management and survival over 22 years. Arch Dis Child 2012, 97:326-330.
70. Jaiyesimi O., Baichoo V. Cardiovascular malformations in Omani Arab children with Down's syndrome. Cardiol Young 2007, 17:166-171.
71. Jefferies J.L., Pignatelli R.H., Martinez H.R., Robbins-Furman P.J., Liu P., Gu W., et al. Cardiovascular findings in duplication 17p11.2 syndrome. Genet Med 2012, 14:90-94.
72. Jenkins K.J., Correa A., Feinstein J.A., Botto L., Britt A.E., Daniels S.R., et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007, 115:2995-3014.
73. Jimenez-Solem E., Andersen J.T., Petersen M., Broedbaek K., Jensen J.K., Afzal S., et al. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012, 2.
74. Johnston J.J., Teer J.K., Cherukuri P.F., Hansen N.F., Loftus S.K., Chong K., et al. Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate. Am J Hum Genet 2010, 86:743-748.
75. Karkera J.D., Lee J.S., Roessler E., Banerjee-Basu S., Ouspenskaia M.V., Mez J., et al. Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans. Am J Hum Genet 2007, 81:987-994.
76. Kelly R.G., Buckingham M.E. The anterior heart-forming field: voyage to the arterial pole of the heart. Trends Genet 2002, 18:210-216.
77. Kirk E.P., Sunde M., Costa M.W., Rankin S.A., Wolstein O., Castro M.L., et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 2007, 81:280-291.
78. Kleefstra T., Brunner H.G., Amiel J., Oudakker A.R., Nillesen W.M., Magee A., et al. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet 2006, 79:370-377.
79. Koide T., Hayata T., Cho K.W. Negative regulation of hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase. Development 2006, 133:2395-2405.
80. Korpal-Szczyrska M., Aleszewicz-Baranowska J., Dorant B., Potaz P., Birkholz D., Kaminska H. Cardiovascular malformations in Turner syndrome. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2005, 11:211-214.
81. Kosaki K., Bassi M.T., Kosaki R., Lewin M., Belmont J., Schauer G., et al. Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. Am J Hum Genet 1999, 64:712-721.
82. Lalani S.R., Shaw C., Wang X., Patel A., Patterson L.W., Kolodziejska K., et al. Rare DNA copy number variants in cardiovascular malformations with extracardiac abnormalities. Eur J Hum Genet 2013, 21:173-181.
83. Lalani S.R., Ware S.M., Wang X., Zapata G., Tian Q., Franco L.M., et al. MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development. Hum Mol Genet 2013, 22:4339-4348.
84. Lederer D., Grisart B., Digilio M.C., Benoit V., Crespin M., Ghariani S.C., et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 2012, 90:119-124.
85. Levin M. Left-right asymmetry in embryonic development: a comprehensive review. Mech Dev 2005, 122:3-25.
86. Levy H.L., Guldberg P., Guttler F., Hanley W.B., Matalon R., Rouse B.M., et al. Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study. Pediatr Res 2001, 49:636-642.
87. Lewin M.B., McBride K.L., Pignatelli R., Fernbach S., Combes A., Menesses A., et al. Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 2004, 114:691-696.
88. Lin A.E., Basson C.T., Goldmuntz E., Magoulas P.L., McDermott D.A., McDonald-McGinn D.M., et al. Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management. Genet Med 2008, 10:469-494.
89. Lin X., Huo Z., Liu X., Zhang Y., Li L., Zhao H., et al. Anovel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. JHum Genet 2010, 55:662-667.
90. Loffredo C.A., Ferencz C., Wilson P.D., Lurie I.W. Interrupted aortic arch: an epidemiologic study. Teratology 2000, 61:368-375.
91. Loffredo C.A., Hirata J., Wilson P.D., Ferencz C., Lurie I.W. Atrioventricular septal defects: possible etiologic differences between complete and partial defects. Teratology 2001, 63:87-93.
92. Lopes Floro K., Artap S.T., Preis J.I., Fatkin D., Chapman G., Furtado M.B., et al. Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. Hum Mol Genet 2011, 20:1097-1110.
93. Loser H., Majewski F. Type and frequency of cardiac defects in embryofetal alcohol syndrome. Report of 16 cases. Br Heart J 1977, 39:1374-1379.
94. Mani A., Radhakrishnan J., Farhi A., Carew K.S., Warnes C.A., Nelson-Williams C., et al. Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder. Proc Natl Acad Sci U S A 2005, 102:2975-2979.
95. Marelli A.J., Mackie A.S., Ionescu-Ittu R., Rahme E., Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007, 115:163-172.
96. Maslen C.L., Babcock D., Robinson S.W., Bean L.J., Dooley K.J., Willour V.L., et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A 2006, 140:2501-2505.
97. Matsson H., Eason J., Bookwalter C.S., Klar J., Gustavsson P., Sunnegardh J., et al. Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet 2008, 17:256-265.
98. McBride K.L., Marengo L., Canfield M., Langlois P., Fixler D., Belmont J.W. Epidemiology of noncomplex left ventricular outflow tract obstruction malformations (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999-2001. Birth Defects Res A Clin Mol Teratol 2005, 73:555-561.
99. McBride K.L., Pignatelli R., Lewin M., Ho T., Fernbach S., Menesses A., et al. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am J Med Genet A 2005, 134:180-186.
100. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006, 79:169-173.
101. Meijer J.M., Pieper P.G., Drenthen W., Voors A.A., Roos-Hesselink J.W., van Dijk A.P., et al. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart 2005, 91:801-805.
102. Michelena H.I., Desjardins V.A., Avierinos J.F., Russo A., Nkomo V.T., Sundt T.M., et al. Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 2008, 117:2776-2784.
103. Miyamoto T., Kitahori K., Miyaji K., Nagata N., Yasui S. Total cavopulmonary connection in a bedridden patient with Sotos syndrome. Asian Cardiovasc Thorac Ann 2003, 11:342-343.
104. Mjaatvedt C.H., Nakaoka T., Moreno-Rodriguez R., Norris R.A., Kern M.J., Eisenberg C.A., et al. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol 2001, 238:97-109.
105. Mohapatra B., Casey B., Li H., Ho-Dawson T., Smith L., Fernbach S.D., et al. Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Hum Mol Genet 2009, 18:861-871.
106. Muir C.S. Incidence of congenital heart disease in Singapore. Br Heart J 1960, 22:243-254.
107. Muncke N., Jung C., Rudiger H., Ulmer H., Roeth R., Hubert A., et al. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 2003, 108:2843-2850.
108. Munroe P.B., Olgunturk R.O., Fryns J.P., Van Maldergem L., Ziereisen F., Yuksel B., et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999, 21:142-144.
109. Nabulsi M.M., Tamim H., Sabbagh M., Obeid M.Y., Yunis K.A., Bitar F.F. Parental consanguinity and congenital heart malformations in a developing country. Am J Med Genet A 2003, 116:342-347.
110. Ng S.B., Bigham A.W., Buckingham K.J., Hannibal M.C., McMillin M.J., Gildersleeve H.I., et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010, 42:790-793.
111. Niebuhr E. The Cri du Chat syndrome: epidemiology, cytogenetics, and clinical features. Hum Genet 1978, 44:227-275.
112. Nora J.J., Nora A.H., Toews W.H. Letter: lithium, Ebstein's anomaly, and other congenital heart defects. Lancet 1974, 2:594-595.
113. Obican S., Scialli A.R. Teratogenic exposures. Am J Med Genet C Semin Med Genet 2011, 157C:150-169.
114. Oyen N., Poulsen G., Boyd H.A., Wohlfahrt J., Jensen P.K., Melbye M. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J 2009, 157:467-473. e1.
115. Oyen N., Poulsen G., Boyd H.A., Wohlfahrt J., Jensen P.K., Melbye M. Recurrence of congenital heart defects in families. Circulation 2009, 120:295-301.
116. Oyen N., Poulsen G., Wohlfahrt J., Boyd H.A., Jensen P.K., Melbye M. Recurrence of discordant congenital heart defects in families. Circ Cardiovasc Genet 2011, 3:122-128.
117. Pereira F.A., Qiu Y., Zhou G., Tsai M.J., Tsai S.Y. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 1999, 13:1037-1049.
118. Piacentini G., Digilio M.C., Capolino R., Zorzi A.D., Toscano A., Sarkozy A., et al. Familial recurrence of heart defects in subjects with congenitally corrected transposition of the great arteries. Am J Med Genet A 2005, 137:176-180.
119. Potocki L., Chen K.S., Park S.S., Osterholm D.E., Withers M.A., Kimonis V., et al. Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet 2000, 24:84-87.
120. Pradat P., Francannet C., Harris J.A., Robert E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol 2003, 24:195-221.
121. Pritchard J.K., Cox N.J. The allelic architecture of human disease genes: common disease-common variant or not?. Hum Mol Genet 2002, 11:2417-2423.
122. Rajagopal S.K., Ma Q., Obler D., Shen J., Manichaikul A., Tomita-Mitchell A., et al. Spectrum of heart disease associated with murine and human GATA4 mutation. JMol Cell Cardiol 2007, 43:677-685.
123. Ramegowda S., Ramachandra N.B. Parental consanguinity increases congenital heart diseases in South India. Ann Hum Biol 2006, 33:519-528.
124. Roberts K.E., McElroy J.J., Wong W.P., Yen E., Widlitz A., Barst R.J., et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 2004, 24:371-374.
125. Robinson S.W., Morris C.D., Goldmuntz E., Reller M.D., Jones M.A., Steiner R.D., et al. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 2003, 72:1047-1052.
126. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
127. Sanchez-Valle A., Pierpont M.E., Potocki L. The severe end of the spectrum: hypoplastic left heart in Potocki-Lupski syndrome. Am J Med Genet A 2011, 155A:363-366.
128. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
129. Schrire V. Experience with congenital heart disease at Groote Schuur hospital, Cape Town. An analysis of 1,439 patients over an eleven-year period. SAfr Med J 1963, 37:1175-1180.
130. Shann M.K. Congenital heart disease in Taiwan, Republic of China. Circulation 1969, 39:251-258.
131. Sheffield V.C., Pierpont M.E., Nishimura D., Beck J.S., Burns T.L., Berg M.A., et al. Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum Mol Genet 1997, 6:117-121.
132. Shuib S., McMullan D., Rattenberry E., Barber R.M., Rahman F., Zatyka M., et al. Microarray based analysis of 3p25-p26 deletions (3p-syndrome). Am J Med Genet A 2009, 149A:2099-2105.
133. Siu S. The risk of congenital heart disease recurrence in the offspring of adults with major heart defects. Evid Based Cardiovasc Med 1998, 2:70.
134. Silversides C.K., Lionel A.C., Costain G., Merico D., Migita O., Liu B., et al. Rare copy number variations in adults with tetralogy of fallot implicate novel risk gene pathways. PLoS Genet 2012, 8:e1002843.
135. Smith K.A., Joziasse I.C., Chocron S., van Dinther M., Guryev V., Verhoeven M.C., et al. Dominant-negative ALK2 allele associates with congenital heart defects. Circulation 2009, 119:3062-3069.
136. Soemedi R., Wilson I.J., Bentham J., Darlay R., Topf A., Zelenika D., et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet 2012, 91:489-501.
137. Sperling S., Grimm C.H., Dunkel I., Mebus S., Sperling H.P., Ebner A., et al. Identification and functional analysis of CITED2 mutations in patients with congenital heart defects. Hum Mutat 2005, 26:575-582.
138. Stankiewicz P., Sen P., Bhatt S.S., Storer M., Xia Z., Bejjani B.A., et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009, 84:780-791.
139. Stennard F.A., Harvey R.P. T-box transcription factors and their roles in regulatory hierarchies in the developing heart. Development 2005, 132:4897-4910.
140. Stevenson R.E., Bennett C.W., Abidi F., Kleefstra T., Porteous M., Simensen R.J., et al. Renpenning syndrome comes into focus. Am J Med Genet A 2005, 134:415-421.
141. Stewart D.R., Kleefstra T. The chromosome 9q subtelomere deletion syndrome. Am J Med Genet C Semin Med Genet 2007, 145C:383-392.
142. Syrmou A., Tzetis M., Fryssira H., Kosma K., Oikonomakis V., Giannikou K., et al. Array comparative genomic hybridization as a clinical diagnostic tool in syndromic and nonsyndromic congenital heart disease. Pediatr Res 2013, 73:772-776.
143. Tabacova S., Little R., Tsong Y., Vega A., Kimmel C.A. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf 2003, 12:633-646.
144. Thienpont B., Mertens L., de Ravel T., Eyskens B., Boshoff D., Maas N., et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J 2007, 28:2778-2784.
145. Thienpont B., Zhang L., Postma A.V., Breckpot J., Tranchevent L.C., Van Loo P., et al. Haploinsufficiency of TAB2 causes congenital heart defects in humans. Am J Hum Genet 2010, 86:839-849.
146. Tidyman W.E., Rauen K.A. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009, 19:230-236.
147. Tumer Z., Harboe T.L., Blennow E., Kalscheuer V.M., Tommerup N., Brondum-Nielsen K. Molecular cytogenetic characterization of ring chromosome 15 in three unrelated patients. Am J Med Genet A 2004, 130A:340-344.
148. Tzemos N., Therrien J., Yip J., Thanassoulis G., Tremblay S., Jamorski M.T., et al. Outcomes in adults with bicuspid aortic valves. JAMA 2008, 300:1317-1325.
149. van Beynum I.M., Kapusta L., Bakker M.K., den Heijer M., Blom H.J., de Walle H.E. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 2010, 31:464-471.
150. van der Bom T., Zomer A.C., Zwinderman A.H., Meijboom F.J., Bouma B.J., Mulder B.J. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011, 8:50-60.
151. van Egmond H., Orye E., Praet M., Coppens M., Devloo-Blancquaert A. Hypoplastic left heart syndrome and 45X karyotype. Br Heart J 1988, 60:69-71.
152. Vissers L.E., van Ravenswaaij C.M., Admiraal R., Hurst J.A., de Vries B.B., Janssen I.M., et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 2004, 36:955-957.
153. Volkl T.M., Degenhardt K., Koch A., Simm D., Dorr H.G., Singer H. Cardiovascular anomalies in children and young adults with Ullrich-Turner syndrome the Erlangen experience. Clin Cardiol 2005, 28:88-92.
154. Ware S.M., Peng J., Zhu L., Fernbach S., Colicos S., Casey B., et al. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet 2004, 74:93-105.
155. Watanabe Y., Benson D.W., Yano S., Akagi T., Yoshino M., Murray J.C. Two novel frameshift mutations in NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. JMed Genet 2002, 39:807-811.
156. Weinstein M.R., Goldfield M. Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 1975, 132:529-531.
157. Warburton D., Ronemus M., Kline J., Jobanputra V., Williams I., Anyane-Yeboa K., et al. The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet 2014, 133:11-27.
158. Whittemore R., Wells J.A., Castellsague X. Asecond-generation study of 427 probands with congenital heart defects and their 837 children. JAm Coll Cardiol 1994, 23:1459-1467.
159. Wichman C.L., Moore K.M., Lang T.R., St Sauver J.L., Heise R.H., Watson W.J. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc 2009, 84:23-27.
160. Wollins D.S., Ferencz C., Boughman J.A., Loffredo C.A. Apopulation-based study of coarctation of the aorta: comparisons of infants with and without associated ventricular septal defect. Teratology 2001, 64:229-236.
161. Wurst K.E., Poole C., Ephross S.A., Olshan A.F. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol 2010, 88:159-170.
162. Yagi H., Furutani Y., Hamada H., Sasaki T., Asakawa S., Minoshima S., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362:1366-1373.
163. Yang X.F., Wu X.Y., Li M., Li Y.G., Dai J.T., Bai Y.H., et al. Mutation analysis of Cited2 in patients with congenital heart disease. Zhonghua Er Ke Za Zhi 2010, 48:293-296.
164. Ye M., Coldren C., Liang X., Mattina T., Goldmuntz E., Benson D.W., et al. Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. Hum Mol Genet 2010, 19:648-656.
165. Yutzey K.E., Kirby M.L. Wherefore heart thou? Embryonic origins of cardiogenic mesoderm. Dev Dyn 2002, 223:307-320.
166. Zaghloul N.A., Katsanis N. Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. JClin Invest 2009, 119:428-437.
167. Zaidi S., Choi M., Wakimoto H., Ma L., Jiang J., Overton J.D., et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013, 498:220-223.
168. Zalzstein E., Moes C.A., Musewe N.N., Freedom R.M. Spectrum of cardiovascular anomalies in Williams-Beuren syndrome. Pediatr Cardiol 1991, 12:219-223.
169. Zavala C., Jimenez D., Rubio R., Castillo-Sosa M.L., Diaz-Arauzo A., Salamanca F. Isolated congenital heart defects in first degree relatives of 185 affected children. Prospective study in Mexico City. Arch Med Res 1992, 23:177-182.
170. Zhu L., Vranckx R., Khau Van Kien P., Lalande A., Boisset N., Mathieu F., et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 2006, 38:343-349.
171. Zweier C., Thiel C.T., Dufke A., Crow Y.J., Meinecke P., Suri M., et al. Clinical and mutational spectrum of Mowat-Wilson syndrome. Eur J Med Genet 2005, 48:97-111.